Seeking Alpha

Salix Pharmaceuticals (SLXP -7.7%) plunges after the FDA provides relatively lenient clinical...

Salix Pharmaceuticals (SLXP -7.7%) plunges after the FDA provides relatively lenient clinical study guidelines (.pdf) for would-be makers of a generic version of Salix's Xifaxan drug. Salix closed yesterday near its 52-week high.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)